NCF2 Gene Granulomatous disease chronic autosomal recessive cytochrome b-positive type 2 Genetic Test sale cost 4400 AED
LAMB3 Gene Epidermolysis bullosa junctional Herlitz type Genetic Test sale cost 4400 AED LAMB3 Gene Epidermolysis bullosa junctional Herlitz type Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CD59 Gene Hemolytic anemia CD59-mediated with or without immune-mediated polyneuropathy Genetic Test sale cost 4400 AED CD59 Gene Hemolytic anemia CD59-mediated with or without immune-mediated polyneuropathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NCF2 Gene Granulomatous disease chronic autosomal recessive cytochrome b-positive type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NCF2 gene plays a critical role in the immune system’s ability to combat infections. Mutations in this gene can lead to a condition known as Chronic Granulomatous Disease (CGD) of the autosomal recessive cytochrome b-positive type 2. CGD is a rare immune disorder characterized by the body’s inability to effectively kill certain bacteria and fungi, leading to repeated infections and the formation of granulomas, which are clusters of immune cells that form at sites of infection or inflammation.

The genetic test for identifying mutations in the NCF2 gene is crucial for the diagnosis and management of CGD. Conducted at DNA Labs UAE, this test is designed to detect specific genetic alterations in the NCF2 gene that are responsible for the condition. By identifying these mutations, healthcare providers can confirm a diagnosis of CGD, enabling them to tailor treatment plans to the individual needs of the patient, potentially improving outcomes and quality of life.

The cost of the NCF2 gene test at DNA Labs UAE is 4400 AED. This test is an important tool for families with a history of CGD or for individuals presenting symptoms suggestive of the disease. Early diagnosis through genetic testing can facilitate timely and appropriate medical interventions, including prophylactic antibiotics, antifungal medications, and potentially gene therapy or bone marrow transplantation, which are considered for severe cases.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-positive Type 2 Genetic Test

At DNA Labs UAE, we offer the NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-positive Type 2 Genetic Test. This test is designed to diagnose and provide important information for the treatment and management of this genetic disorder.

Test Components

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information

Before undergoing the NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-positive Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with this genetic disorder.

Test Details

The NCF2 gene is associated with chronic granulomatous disease (CGD), an inherited immune system disorder characterized by recurrent infections and the formation of granulomas. CGD is caused by mutations in genes involved in the production of reactive oxygen species (ROS) by immune cells.

The NCF2 gene provides instructions for making a protein called p67phox, which is a subunit of the NADPH oxidase enzyme complex. This complex is responsible for producing ROS, which are crucial for the killing of bacteria and fungi by immune cells.

Mutations in the NCF2 gene can result in a deficiency or dysfunction of the p67phox protein, leading to a reduced ability of immune cells to produce ROS and effectively fight off infections.

CGD is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

The cytochrome b-positive, type 2 NGS genetic test is a specific type of genetic test that can identify mutations in the NCF2 gene associated with CGD. This test utilizes next-generation sequencing (NGS) technology to analyze the DNA sequence of the NCF2 gene and detect any disease-causing mutations.

Treatment and Management

Once a diagnosis of CGD is confirmed through genetic testing, treatment typically involves antibiotic and antifungal medications to control infections. Additionally, other therapies may be utilized to boost the immune system’s ability to fight off infections.

By offering the NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-positive Type 2 Genetic Test, DNA Labs UAE aims to provide accurate diagnosis and personalized treatment plans for individuals with this genetic disorder.

Test Name NCF2 Gene Granulomatous disease chronic autosomal recessive cytochrome b-positive type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NCF2 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NCF2 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 NGS Genetic DNA Test gene NCF2
Test Details

The NCF2 gene is associated with chronic granulomatous disease (CGD), which is an inherited immune system disorder characterized by recurrent infections and the formation of granulomas, which are clusters of immune cells that cause inflammation. CGD is caused by mutations in genes involved in the production of reactive oxygen species (ROS) by immune cells.

The NCF2 gene provides instructions for making a protein called p67phox, which is a subunit of the NADPH oxidase enzyme complex. This enzyme complex is responsible for producing ROS, which are crucial for the killing of bacteria and fungi by immune cells. Mutations in the NCF2 gene can lead to a deficiency or dysfunction of the p67phox protein, resulting in a reduced ability of immune cells to produce ROS and effectively fight off infections.

CGD is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. The cytochrome b-positive, type 2 NGS genetic test is a specific type of genetic test that can be used to identify mutations in the NCF2 gene associated with CGD. This test uses next-generation sequencing (NGS) technology to analyze the DNA sequence of the NCF2 gene and detect any disease-causing mutations.

Identifying mutations in the NCF2 gene through genetic testing can help confirm a diagnosis of CGD and provide important information for treatment and management of the condition. Treatment for CGD typically involves antibiotic and antifungal medications to control infections, as well as other therapies to boost the immune system’s ability to fight off infections.

SKU: TEST-3005 Category:

Related products